blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3371200

EP3371200 - TRIGGER-ACTIVATABLE METABOLIC SUGAR PRECURSORS FOR CANCER-SELECTIVE LABELING AND TARGETING [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  13.05.2022
Database last updated on 13.11.2024
FormerRequest for examination was made
Status updated on  10.08.2018
FormerThe international publication has been made
Status updated on  18.04.2017
Most recent event   Tooltip28.10.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
The Board of Trustees of the University of Illinois
352 Henry Administration Building
506 South Wright Street
Urbana, IL 61801 / US
[2018/37]
Inventor(s)01 / CHENG, Jianjun
2304 Lynwood Drive
Champaign, IL 61821 / US
02 / WANG, Hua
38 Craigie Street Apt 2
Somerville, MA 02143 / US
 [2018/37]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[N/P]
Former [2018/37]HGF Limited
1 City Walk
Leeds LS11 9DX / GB
Application number, filing date16854444.307.10.2016
[2018/37]
WO2016US56046
Priority number, dateUS201562238326P07.10.2015         Original published format: US 201562238326 P
[2018/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017062800
Date:13.04.2017
Language:EN
[2017/15]
Type: A1 Application with search report 
No.:EP3371200
Date:12.09.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 13.04.2017 takes the place of the publication of the European patent application.
[2018/37]
Search report(s)International search report - published on:US13.04.2017
(Supplementary) European search report - dispatched on:EP31.03.2020
ClassificationIPC:C07H15/18, C07H15/26, A61K31/7034, A61K31/7042, A61P35/00
[2020/04]
CPC:
C07H15/26 (EP,KR,US); C07H15/18 (EP,KR,US); A61K47/552 (US);
A61P35/00 (EP,KR,US); G01N33/57492 (US)
Former IPC [2018/37]C07H15/00, A61K31/7034, A61K31/7042
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/37]
TitleGerman:ÜBER TRIGGER AKTIVIERBARE METABOLISCHE ZUCKERVORLÄUFER FÜR KREBSSELEKTIVE MARKIERUNG UND ABZIELUNG[2018/37]
English:TRIGGER-ACTIVATABLE METABOLIC SUGAR PRECURSORS FOR CANCER-SELECTIVE LABELING AND TARGETING[2018/37]
French:PRÉCURSEURS MÉTABOLIQUES DE SUCRE, ACTIVABLES PAR UN DÉCLENCHEUR POUR LE MARQUAGE ET LE CIBLAGE SÉLECTIF D'UN CANCER[2018/37]
Entry into regional phase26.04.2018National basic fee paid 
26.04.2018Search fee paid 
26.04.2018Designation fee(s) paid 
26.04.2018Examination fee paid 
Examination procedure26.04.2018Examination requested  [2018/37]
26.04.2018Date on which the examining division has become responsible
21.10.2020Amendment by applicant (claims and/or description)
13.05.2022Despatch of a communication from the examining division (Time limit: M04)
02.09.2022Reply to a communication from the examining division
07.08.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
29.10.2018Renewal fee patent year 03
28.10.2019Renewal fee patent year 04
27.10.2020Renewal fee patent year 05
27.10.2021Renewal fee patent year 06
27.10.2022Renewal fee patent year 07
27.10.2023Renewal fee patent year 08
28.10.2024Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2014065661  (SYNAFFIX BV [NL]);
International search[Y]US2008132458  (MATTEUCCI MARK [US], et al) [Y] 6, 7 * para [0026] *;
 [A]US2010160299  (BAKER JR JAMES R [US], et al) [A] 37-40, 42-43, 62* Figure 3; Figure 16 *;
 [YA]US2014010763  (SHABAT DORON [IL], et al) [Y] 1-18 * para [0022]-[0029]:[0292]-[0294]; Figures 25, 27 and 29c * [A] 20-23, 34-40, 42, 43, 62;
 [YA]US2014031535  (JEFFREY SCOTT [US]) [Y] 1-18 * para [0012];[0016];[0021]-[0031]:[0133];[0134][0329]:[0330]:[0366]:[0376]:[0378]:[0379]:[0380];[0700];[0718];[0719] * [A] 20-23, 34-40, 42, 43, 62;
 [YA]US2014046051  (VRASIDAS IOANNIS [GR], et al) [Y] 1-18 * para [0092];[0106];[0119] * [A] 20-23, 34-36;
 [Y]  - AMSBERRY et al., "Amine Prodrugs Which Utilize Hydroxy Amide Lactonization. 1.", A Potential Redox-Sensitive Amide Prodrug in Pharmaceutical Research, (19910000), vol. 8, pages 323 - 330, XP000609337 [Y] 11-13 * . pg 323, Col 2, para 1 to pg 324, Col 1, para 1, Figure 1; pg 329, Col 1, para 2; Col 2, para 1 *

DOI:   http://dx.doi.org/10.1023/A:1015885213625
ExaminationWO2014202775
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.